Lackey.png

Leila Lackey

FDA

Leila Lackey is the Program Lead for Decision Support at FDA’s Center for Drug Evaluation and Research, Decision Support and Analysis Staff (DSAS). This group provides benefit-risk and decision analysis expertise for regulatory and policy decisions at the Center and led development of the Draft Guidance for Industry on Benefit-Risk Assessment for Human Drugs and Biologics. She has a Master of Health Science from Johns Hopkins in Environmental Health Sciences and a doctorate from UCLA in Environmental Science and Engineering and currently serves on the ASA/DIA Benefit-Risk Assessment Planning Taskforce as well as the Bayesian Scientific Working Group Benefit-Risk Subteam.